Richard Channick, MD (Judge)
Professor of Medicine
Division of Pulmonary and
Critical Care Medicine
David Geffen School of Medicine at
UCLA, Los Angeles, CA
Rajan Saggar, MD (Attorney-Pro)
Professor of Medicine
Co-Director, Pulmonary Vascular
Disease Program
Co-Director,
Medical Intensive Care Unit
Lung & Heart-Lung Transplant and
Pulmonary Hypertension Programs
David Geffen School of Medicine
UCLA Medical Center, Los Angeles, CA
Jean Elwing, MD (Attorney-Con)
Professor of Medicine
Division of Pulmonary,
Critical Care and Sleep Medicine
Director, Pulmonary
Hypertension Program
University of Cincinnati, Cincinnati, OH
Ioana Preston, MD (Witness)
Associate Professor of Medicine
Tufts University School of Medicine
Director, Pulmonary
Hypertension Center
Director, Pulmonary Function Test Lab
Pulmonary, Critical Care
and Sleep Division
Tufts Medical Center, Boston, MA
Victor Tapson, MD (Witness)
Professor of Medicine
Division of Pulmonary & Critical Care
Cedars-Sinai Medical Center, Los
Angeles, CA
Full Accreditation and Program Information
5:30 pm
–
Welcome, Overview & Opening Scene: Introduction to the virtual courtroom concept & judge, prosecutor & defense opening remarks on the case topic
5:40 pm
–
Prosecutor examines witness & defense cross examines witness
5:55 pm
–
Defense attorney examines witness and prosecutor cross examines witness
6:10 pm
–
Attorney Closing arguments
6:20 pm
–
Judge concludes case and refers verdict determinization to the audience (jurors)
6:25 pm
–
Verdict is read with live Q.A to follow
Target Audience
This activity has been designed to meet the educational needs of physicians, registered nurses and other healthcare professionals involved in the care of patients with pulmonary hypertension.
Learning Objectives
After completing this activity, the participant should be better able to:
- Evaluate New WHO Proceeding recommendations for non-Group 1 PH
- Identify issues surrounding variants of PH and incorporate current clinical trials further examining disease etiology
- Assess current practice guidelines and updates for CTEPH, specifically regarding treatment goals
- Discuss issues surrounding CTEPH and highlight current medical and surgical interventions
- Review recent or ongoing clinical trials examining non-Group 1 pulmonary hypertension or studies of non-idiopathic Group 1 PH
Exclusive! Pre and Post-Meeting Content
Experience a new way to learn. Receive pre-meeting content and post-meeting quizzes to enhance your learning experience. Register now to access exclusive content and fully experience the benefits of this interactive program.